Investigating how obesity affects the response to metformin in endometrial cancer
Official title: Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
Funded at Univ of North Carolina Chapel Hill · NIH-10790007 · Data updated 2026-11-12
This study is looking at how the diabetes medication metformin might help treat endometrial cancer in people with obesity and diabetes, and it aims to find out which patients could benefit the most from this treatment.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | March 14, 2018 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $337,922 |
| NIH project number | 5R37CA226969-07 |
| Project ID | NIH-10790007 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are obese patients diagnosed with endometrial cancer who are also managing type 2 diabetes.
✕Less likely to help
Patients with endometrial cancer who are not obese or do not have diabetes may not benefit from this research.
What this research studies
This research explores the relationship between obesity, diabetes, and endometrial cancer outcomes, focusing on how metformin, a diabetes medication, may help treat this cancer. The study examines the metabolic changes induced by metformin and its potential anti-cancer effects by analyzing gene expression patterns in tumors from obese and non-obese patients. By conducting a clinical trial, the researchers aim to identify specific biomarkers that predict which patients will respond best to metformin treatment, potentially leading to more personalized therapies for endometrial cancer.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for endometrial cancer patients, particularly those who are obese or have diabetes.
How similar studies have gone: Previous studies have shown promising results regarding the use of metformin in cancer treatment, indicating that this approach may be effective.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Bae-Jump, Victoria Lin — Univ of North Carolina Chapel Hill
- Study coordinator: Bae-Jump, Victoria Lin
Related research
Other NIH-funded projects on the same topics.
-
Obesity-related metabolic changes and disparities in endometrial cancer
This project looks at why endometrial cancer is worse for Black women and whether obesity-related metabolic changes drive the disease, with aims to find ways to prevent or slow progression.
-
Investigating how obesity affects protein quality control in endometrial cancer
This study is looking at how being overweight might affect the way cancer cells in the uterus work, especially in women with endometrial cancer, to help find better ways to prevent and treat this type of cancer.
-
Investigating how progesterone receptors work in obesity to prevent endometrial cancer
This study is looking at how being overweight might affect the way certain hormones work in the uterus, especially in women at risk for endometrial cancer, to find out how we can better prevent this type of cancer.
-
How obesity affects cancer treatment in endometrial cancer patients
This study is looking at how being overweight affects the success of certain cancer treatments for women with endometrial cancer, and it aims to find better ways to help those patients by combining two specific medications.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Understanding how maternal and infant sleep and daily rhythms influence early appetite and obesity risk
This project explores how infant sleep, circadian rhythms, and maternal-infant timing relate to early appetite patterns and the risk of obesity in the first year of life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.